Efficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma

British Journal of Cancer

Volumn 73, Issue 8, 1996, Pages 989-994

  Goebel, F D ^a   Goldstein, D ^b   Goos, M ^c   Jablonowski, H ^d   Stewart, J S ^e  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e ST MARY S HOSPITAL   (United Kingdom)

Author keywords

AIDS; Kaposi's sarcoma; Liposomal doxorubicin

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DOXORUBICIN; LIPOSOME;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONSTIPATION; DISEASE COURSE; DRUG EFFICACY; DYSPNEA; EDEMA; FEMALE; FLUSHING; HEART FAILURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TACHYCARDIA; THORAX PAIN; THROMBOPHLEBITIS; VERTIGO; VOMITING;

EID: 0029670158     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.193     Document Type: Article

References (34)

1. CENTERS FOR DISEASE CONTROL UPDATE. (1986). Acquired immunodeficiency syndrome (AIDS) - United States. MMWR, 35, 757-760, 765-766.
2. DES JARLAIS DC, STONEBURNER R, THOMAS P AND FRIEDMAN SR. (1987). Declines in proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City (letter). Lancet, 2, 1024-1025.
3. FISCHL MA, DICKINSON GM AND LA VOIE L. (1988). Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA, 259, 1185-1189.
4. FISCHL MA, KROWN, SE, O'BOYLE KP, MITSUYASU R, MILES S, WERNZ JC, VOLBERDING PA, KAHN J, GROOPMAN JE, FEINBERG J, WOODY M AND THE AIDS CLINICAL TRIALS GROUP. (1993). Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. J. Acquir. Immune Defic. Syndr., 6, 259-264.
5. 3: a cost-effectiveness analysis. J. Acquir. Immune Defic. Syndr., 4, 521-531.
6. GABIZON A, CATANE R, UZIELY B, KAUFMAN B, TAMAR S, COHEN R, MARTIN F, HUANG A AND BARENHOLZ Y. (1994). Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res., 54, 987-992.
7. GALLANT JE, MOORE RD, RICHMAN DD, KERULY J, CHAISSON RE AND THE ZIDOVUDINE EPIDEMIOLOGY STUDY GROUP. (1992). Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J. Infect. Dis., 166, 1223-1227.
8. GELMANN EP, LONGO D, LANE HC, FAUCI AS, MASUR H, WESLEY M, PREBLE OT, JACOB J AND STEIS R. (1987). Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. Am. J. Med., 82, 456-462.
9. GILL PS, RARICK MU, BERNSTEIN-SINGER M, HARB M, ESPINA BM, SHAW V AND LEVINE A. (1990a). Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am. J. Clin. Oncol. (CCT), 13, 315-319.
10. GILL PS, RARICK MU, ESPINA B, LOUEIRO C, BERNSTEIN-SINGER M, AKIL B AND LEVINE AM. (1990b). Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Cancer, 65, 1074-1078.
11. GILL PS, RARICK M, MCCUTCHAN JA, SLATER L, PARKER B, MUCHMORE E, BERNSTEIN-SINGER M, AKIL B, ESPINA BM, KRAILO M AND LEVINE A. (1991). Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am. J. Med., 90, 427-433.
12. GORDON KB, TAJUDDIN A, GUITART J, KUZEL TM, ERAMO LR AND VONROEN J. (1995). Hand foot syndrome associated with liposome-encapsulated doxorubicin therapy. Cancer, 75, 2169-2173.
13. GRODY WW, CHENG L AND LEWIS W. (1990). Infection of the heart by the human immunodeficiency virus. Am. J. Cardiol., 66, 203-206.
14. HENGGE UR, BROCKMEYER HN, RAßHOFER R AND GOOS M. (1993). Fatal hepatic failure with liposomal doxorubicin (letter). Lancet, 341, 383-384.
15. HIRSCHEL B, LAZZARIN A, CHOPARD P, OPRAVIL M, FURRER HJ, RUTTIMANN F, VERNAZZA P, CHAVE JP, ANCARANI F AND GABRIEL V. (1991). A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N. Engl. J. Med., 324, 1079-1083.
16. KAPLAN L, ABRAMS D AND VOLBERDING P. (1986). Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen. Cancer Treat. Rep., 70, 1121-1122.
17. KROWN SE, METROKA C AND WERNZ JC. (1989). Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J. Clin. Oncol., 7, 1201-1207.
18. LANE HC, KOVACS JA, FEINBERG J, HERPIN B, DAVEY V, WALKER R, DEYTON L, METCALF JA, BASELER M AND SALZMAN N. (1988). Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma. Lancet, 2, 1218-1222.
19. LASSOUED K, CLAUVEL J.-P, KATLAMA C, JANIER M, PICARD C AND MATHERON S. (1990). Treatment of the acquired immune deficiency syndrome-related Kaposi's sarcoma with bleomycin as a single agent. Cancer, 66, 1869-1872.
20. LAUDENSTEIN LJ, KRIGEL RL, ODAJNYK CM, HYMES KB, FRIEDMAN-KIEN A, WERNZ JC AND MUGGIA FM. (1984). Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J. Clin. Oncol., 2, 1115-1120.
21. LOKICH JJ AND MOORE C. (1984). Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann. Int. Med., 101, 798-800.
22. MASUR H, OGNIBENE FP, YARCHOAN R, SHELHAMER JH, BAIRD BF, TRAVIS W, SUFFREDINI AF, DEYTON L, KOVACS JA, FALLOON J, DAVEY R, POLIS M, METCALF J, BASELER M, WESLEY R, GILL VJ, FAUCI AS AND LANE HC. (1989). CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infections. Ann. Int. Med., 111, 223-231.
23. MINTZER DM, REAL FX, JOVINO L AND KROWN SE. (1985). Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann. Int. Med., 102, 200-202.
24. NORTHFELT DW, KAPLAN LD, RUSSELL J, VOLBERDING PA AND MARTIN FJ. (1995). Pharmacokinetics and tumor localization of DOX-SL™ (Stealth® liposomal doxorubicin) by comparison with Adriamycin in patients with AIDS and Kaposi's sarcoma. In Stealth® Liposomes, Lasic D and Martin F. (eds) pp. 257-266. CRC Press: Boca Raton.
25. PAPAHADJOPOULOS D, ALLEN TM, GABIZON A, MAYHEW E, MATTHAY K, HUANG SK, LEE K.-D, WOODLE MC, LASIC DD, REDEMANN C AND MARTIN FJ. (1991). Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl Acad. Sci. USA, 88, 11460-11464.
26. PAYNE TH, COHN DL, DAVIDSON AJ, HENRY TD, SCHAEFFER JW AND GABOW PA. (1991). Marked elevations of serum alkaline phosphatase in patients with AIDS. J. Acquir. Immune Defic. Syndro., 4, 238-243.
27. PETERS BS, BECK EJ, COLEMAN DG, WADSWORTH MJH, MCGUINNESS O, HARRIS JRW AND PINCHING AJ. (1991). Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. Br. Med. J., 302, 203-207.
28. PRESANT CA, SCOLARO M, KENNEDY P, BLAYNEY DW, FLANAGAN B, LISAK J AND PRESANT J. (1993). Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet, 341, 1242-1243.
29. RAHMAN A, TREAT J, ROH J.-K, POTKUL LA, ALVORD WG, FORST D AND WOOLLEY PV. (1990). A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin. J. Clin. Oncol., 8, 1093-1100.
30. UZIELY B, JEFFERS S, ISACSON R, KUTSCH K, WEI-TSAO D, YEHOSHUA Z, LIBSON E, MUGGIA FM AND GABIZON A. (1995). Liposomal doxorubicin (DOX-SL®): antitumor activity and unique toxicities during two complementary phase I studies. J. Clin. Oncol., 13, 1777-1785.
31. VAAGE J, MAYHEW E, LASIC D AND MARTIN F. (1992). Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int. J. Cancer, 51, 942-948.
32. VOGELZANG NJ AND RATAIN MJ. (1985). Cancer chemotherapy and skin changes (letter). Ann. Int. Med., 103, 303-304.
33. VOLBERDING PA, ABRAMS DI, CONANT M, KASLOW K, VRANIZAN K AND ZIEGLER J. (1985). Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann. Int. Med., 103, 335-338.
34. VOLBERDING PA, KUSICK P AND FEIGAL DW. (1989). Effect of chemotherapy for HIV associated Kaposi's sarcoma on long-term survival (abstract no. 11). In Program and abstracts of the 8th Annual Meeting of the American Society of Clinical Oncology. Chicago, IL: American Society of Clinical Oncology, pp. 3.